Cardiovascular Revascularization Medicine
Volume 9, Issue 3 , Pages 179-181 , July 2008

Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy

Received 12 May 2007 ,Revised 22 June 2007

References 

  1. Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS, et al. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol. 2002;40(9):1567–1572
  2. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364(9444):1519–1521
  3. Henderson D, Gunalingam B. Very late stent thrombosis of a sirolimus-eluting stent. Catheter Cardiovasc Interv. 2006;68(3):406–408
  4. Glowczynska R, Malek LA, Spiewak M, Filipiak KJ, Grabowski M, Kisiel B, et al. Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis—a case report and review of the literature. Int J Cardiol. 2006;111(2):326–328
  5. Acar G, Dogan A, Altinbas A, Turker Y. Recurrent acute stent thrombosis associated with protein C and S deficiencies. Int J Cardiovasc Imaging. 2006;22(3–4):333–337
  6. Templin C, Schaefer A, Stumme B, Drexler H, von Depka M. Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis. Clin Res Cardiol. 2006;95(2):122–126
  7. Kitazume R, Yasuga Y, Hayashi N, Takeda Y, Nakagawa Y, Nojima Y, et al. Young woman with repeated late stent thrombosis: a case report. J Cardiol. 2005;45(1):19–26
  8. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–2130
  9. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45(7):995–998
  10. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47(10):2108–2111
  11. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention–summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv. 2006;67(1):87–112
  12. Brilakis ES, Benerjee S, Berger PB. Perioperative management of coronary stents. J Am Coll Cardiol. 2007;49(22):2145–2150
  13. Lee S-W, Park S-W, Hong M-K, Kim Y-H, Lee B-K, Song J-M, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol. 2005;46(10):1833–1837
  14. Wenaweser P, Dorffler-Melly J, Imboden K, Windecker S, Togni M, Meier B, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol. 2005;45(11):1748–1752

☆ Emmanouil S. Brilakis received support from the Clark R. Gregg Fund of the Harris Methodist Health Foundation (Fort Worth, TX) and a Veterans Affairs VISN 17 startup award (Waco, TX).

PII: S1553-8389(07)00256-4

doi: 10.1016/j.carrev.2007.06.003

Cardiovascular Revascularization Medicine
Volume 9, Issue 3 , Pages 179-181 , July 2008

Article Tools

* Image Usage & Resolution